C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 279/02 (2006.01) A61K 31/155 (2006.01) A61K 31/16 (2006.01) A61K 31/4164 (2006.01) A61K 31/47 (2006.01)
Patent
CA 2546602
Monoacyl - substituted guanidines of the formula III (see formula III) are described where X(2) is (see formula I) as are the pharmaceutically tolerated salts thereof. They are outstandingly suitable for use as antiarrhythmic pharmaceuticals possessing a cardioprotective component for the prophylaxis and treatment of infarction and for the treatment of angina pectoris, in connection with which they also inhibit or strongly reduce, in a preventive manner, the pathophysiological processes associated with the genesis of ischemically induced damage, in particular associated with the elicitation of ischemically induced cardiac arrhythmias. On account of their protective effects against pathological hypoxic and ischemic situations, the compounds of the formula I according to the invention can, as a consequence of inhibiting the cellular Na+/H+ exchange mechanism, be used as pharmaceuticals for treating all acute or chronic damage eliciated by ischemia, or diseases induced primarily or secondarily thereby.
Albus Udo
Crause Peter
Kleemann Heinz-Werner
Lang Hans-Hochen
Scholz Wolfgang
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
LandOfFree
Monoacyl-substituted guanidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoacyl-substituted guanidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoacyl-substituted guanidines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2075372